With a value of USD 5.22 billion in 2024, the global human papillomavirus (HPV) vaccine market is expanding due to rising HPV-related cases and innovations in vaccine delivery. Anticipated to grow at a CAGR of 11.60% through 2025–2034, the market is projected to hit USD 13.96 billion by 2034, supporting global efforts in preventive healthcare and immunization programs. https://www.expertmarketresearch.com/reports/human-papillomavirus-hpv-vaccine-market